Gypenoside A

Gypenoside A at a Glance

Gypenoside A is one of the dammarane-type triterpenoid saponins — the gypenosides — that make up the active fraction of jiaogulan (Gynostemma pentaphyllum), the climbing vine sold as “southern ginseng.” It is a large, sugar-decorated molecule of the same structural family as the ginseng saponins, and it shares their defining practical weakness: it is barely absorbed when taken by mouth ^{2Reference 2Li X et al. · 2025ReviewGypenosides, a promising phytochemical triterpenoid: research progress on its pharmacological activity and mechanism — reviewView study →}.

As an isolated compound, gypenoside A is thinly studied. Its one dedicated study is an anti-inflammatory, anti-asthma signal in mice ^{1Reference 1Huang WC et al. · 2022AnimalGypenoside A from Gynostemma pentaphyllum attenuates airway inflammation and Th2 cell activities in a murine asthma model — animal modelView study →}. The metabolic, anti-fatigue and antidepressant effects that jiaogulan is better known for belong to the whole gypenoside mixture — or to other named gypenosides — not to gypenoside A specifically. That distinction runs through this whole page: jiaogulan is a genuine, actively-researched herb, but “gypenoside A” is a small, largely uncharacterised slice of it.

A Jiaogulan Dammarane Saponin

Jiaogulan’s chemistry is dominated by the gypenosides, a family of 200-plus dammarane-type triterpenoid saponins (up to ~328 counted across the Gynostemma genus) ^{3Reference 3Nguyen NH et al. · 2021ReviewTriterpenoids from the genus Gynostemma: chemistry and pharmacological activities — reviewView study →}. Gypenoside A is one named member of that large set. Total saponins make up roughly 2.4% of the dried leaf, and — importantly for reading any jiaogulan study — about a quarter of that saponin pool is structurally identical to the ginsenosides of true ginseng (Rb1, Rb3, Rd and related molecules) ^{4Reference 4Razmovski-Naumovski V et al. · 2005ReviewChemistry and pharmacology of Gynostemma pentaphyllum — reviewView study →}. That overlap is why Gynostemma earned the nickname “southern ginseng.”

Two facts about this molecule are worth holding onto before the evidence:

• Human studies use a mixture, never gypenoside A alone. Jiaogulan’s clinical work is on whole-leaf tea or standardised leaf extracts — often standardised to a different saponin, gypenoside L — in which gypenoside A is one component among hundreds ^{3,6Reference 3Nguyen NH et al. · 2021ReviewTriterpenoids from the genus Gynostemma: chemistry and pharmacological activities — reviewView study →Reference 6Ahn YJ et al. · 2023RCTEffects of gypenoside L-containing Gynostemma pentaphyllum extract on fatigue and physical performance: a double-blind, placebo-controlled, randomized trial — human RCTView study →}. No single gypenoside is reliably standardised across products, and profiles shift with cultivar, ploidy and processing ^{3Reference 3Nguyen NH et al. · 2021ReviewTriterpenoids from the genus Gynostemma: chemistry and pharmacological activities — reviewView study →}.
• Isolate-A data is scarce. Where a laboratory has actually isolated gypenoside A and tested it on its own, the record is essentially a single murine asthma study ^{1Reference 1Huang WC et al. · 2022AnimalGypenoside A from Gynostemma pentaphyllum attenuates airway inflammation and Th2 cell activities in a murine asthma model — animal modelView study →}. Everything else attributed to “gypenosides” is either the mixture or a sibling molecule such as gypenoside L (fatigue/exercise), gypenoside IX (cognition) or gypenoside XVII (mood) ^{6,8,10Reference 6Ahn YJ et al. · 2023RCTEffects of gypenoside L-containing Gynostemma pentaphyllum extract on fatigue and physical performance: a double-blind, placebo-controlled, randomized trial — human RCTView study →Reference 8Lei H et al. · 2023Gypenoside IX restores Akt/GSK-3β pathway and alleviates Alzheimer’s disease-like neuropathology and cognitive deficits — animal/cell modelView study →Reference 10Zhang MM et al. · 2022AnimalGypenoside XVII, an active ingredient from Gynostemma pentaphyllum, inhibits C3aR-associated synaptic pruning in stressed mice — animal modelView study →}.

So the honest headline is that gypenoside A is a real but minor and largely uncharacterised member of a well-studied saponin family. It should be read as part of the jiaogulan story, not as a stand-alone actor.

What It's Used For

The evidence divides sharply between the one thing tested on isolated gypenoside A and the much larger body of work on the mixture and its siblings. Read the per-row basis carefully — most of what follows is not, strictly, gypenoside A.

Evidence by IndicationStrength of support · Beta

Support is an experimental score — weighted by study type (human > animal > in vitro) and volume, and tempered heavily here because so little rests on the isolated molecule. A beta, not a validated metric. Every row states whether it is gypenoside A or the wider mixture/siblings.

01Metabolic, AMPK & Exercise PerformanceShaky24%Two human trials — but of whole/gypenoside-L extract, not isolate A ^{6,7Reference 6Ahn YJ et al. · 2023RCTEffects of gypenoside L-containing Gynostemma pentaphyllum extract on fatigue and physical performance: a double-blind, placebo-controlled, randomized trial — human RCTView study →Reference 7Nayyar D et al. · 2023Clinical trialGynostemma pentaphyllum increases exercise performance and alters mitochondrial respiration and AMPK in healthy males — human studyView study →}

02Airway Inflammation / Anti-Asthma (Th2)Shaky22%The single isolated-gypenoside-A study; one murine model ^{1Reference 1Huang WC et al. · 2022AnimalGypenoside A from Gynostemma pentaphyllum attenuates airway inflammation and Th2 cell activities in a murine asthma model — animal modelView study →}

03Neuroinflammation & MoodShaky15%Gypenosides class + siblings XVII/GP-14, not isolate A ^{9,10Reference 9Dong SQ et al. · 2018AnimalGypenosides reverses depressive behavior via inhibiting hippocampal neuroinflammation — animal modelView study →Reference 10Zhang MM et al. · 2022AnimalGypenoside XVII, an active ingredient from Gynostemma pentaphyllum, inhibits C3aR-associated synaptic pruning in stressed mice — animal modelView study →}

Mechanisms

Only the top row is a demonstrated action of isolated gypenoside A. The rest are family-level mechanisms shown for the mixture or for sibling saponins, listed to map where gypenoside A might plausibly sit — not to claim them for it.

Pharmacokinetics

Poor oral absorption is the load-bearing fact. Gypenoside A is a large, polar, multiply-glycosylated saponin, so very little crosses the gut wall intact: a 2025 pharmacology review puts the oral bioavailability of gypenoside A at roughly 0.90%, against ~1.2% for total gypenosides and as low as 0.14% for some individual members ^{2Reference 2Li X et al. · 2025ReviewGypenosides, a promising phytochemical triterpenoid: research progress on its pharmacological activity and mechanism — reviewView study →}. As with the ginsenosides, the intact saponin is progressively deglycosylated by gut bacteria into smaller, more absorbable aglycone-leaning metabolites, so much of any systemic exposure is to secondary products rather than to gypenoside A itself ^{2Reference 2Li X et al. · 2025ReviewGypenosides, a promising phytochemical triterpenoid: research progress on its pharmacological activity and mechanism — reviewView study →}. The practical consequence mirrors ginsenoside Rb1 and ginsenoside Rg1: cell-culture and injected-animal potencies do not map cleanly onto what an oral dose delivers, and the absence of a defined extraction standard means real-world exposure to gypenoside A varies widely between products ^{2,3Reference 2Li X et al. · 2025ReviewGypenosides, a promising phytochemical triterpenoid: research progress on its pharmacological activity and mechanism — reviewView study →Reference 3Nguyen NH et al. · 2021ReviewTriterpenoids from the genus Gynostemma: chemistry and pharmacological activities — reviewView study →}.

Clinical Trials

There are no clinical trials of isolated gypenoside A. The human evidence associated with jiaogulan is all at the whole-extract or gypenoside-L-standardised level — an exercise/fatigue RCT ^{6Reference 6Ahn YJ et al. · 2023RCTEffects of gypenoside L-containing Gynostemma pentaphyllum extract on fatigue and physical performance: a double-blind, placebo-controlled, randomized trial — human RCTView study →} and an exercise/AMPK study ^{7Reference 7Nayyar D et al. · 2023Clinical trialGynostemma pentaphyllum increases exercise performance and alters mitochondrial respiration and AMPK in healthy males — human studyView study →} — so no clinical outcome can be attributed to gypenoside A specifically.

Last checked: July 2026.

Isolate vs. Plant Studies

This molecule sits at the far plant/mixture end of the isolate-vs-plant spectrum. The isolated-compound record is essentially one animal study (murine asthma) ^{1Reference 1Huang WC et al. · 2022AnimalGypenoside A from Gynostemma pentaphyllum attenuates airway inflammation and Th2 cell activities in a murine asthma model — animal modelView study →}; there is no human data on gypenoside A alone. Everything with clinical weight belongs to jiaogulan as a whole — whole-leaf tea, or leaf extracts standardised (when standardised at all) to a different saponin, gypenoside L ^{6,7Reference 6Ahn YJ et al. · 2023RCTEffects of gypenoside L-containing Gynostemma pentaphyllum extract on fatigue and physical performance: a double-blind, placebo-controlled, randomized trial — human RCTView study →Reference 7Nayyar D et al. · 2023Clinical trialGynostemma pentaphyllum increases exercise performance and alters mitochondrial respiration and AMPK in healthy males — human studyView study →}. Because Gynostemma carries 200-plus dammarane saponins with no single member reliably standardised across products ^{3Reference 3Nguyen NH et al. · 2021ReviewTriterpenoids from the genus Gynostemma: chemistry and pharmacological activities — reviewView study →}, and because roughly a quarter of them are shared with Panax ginseng ^{4Reference 4Razmovski-Naumovski V et al. · 2005ReviewChemistry and pharmacology of Gynostemma pentaphyllum — reviewView study →}, any “jiaogulan effect” is the sum of a shifting mixture — impossible to pin on gypenoside A. Treat the herb page, not this molecule page, as where jiaogulan’s human evidence lives.

Prevalence in Nature

Gypenoside A occurs in jiaogulan (Gynostemma pentaphyllum), chiefly the leaf, as one member of the plant’s large dammarane-saponin family — a family numbering more than 200 structures in G. pentaphyllum and up to ~328 across the wider genus ^{3Reference 3Nguyen NH et al. · 2021ReviewTriterpenoids from the genus Gynostemma: chemistry and pharmacological activities — reviewView study →}. Total saponins make up around 2.4% of the dried plant, but the concentration of gypenoside A specifically is not well characterised, and it varies with cultivar, ploidy (diploid vs tetraploid lines) and post-harvest processing ^{3,4Reference 3Nguyen NH et al. · 2021ReviewTriterpenoids from the genus Gynostemma: chemistry and pharmacological activities — reviewView study →Reference 4Razmovski-Naumovski V et al. · 2005ReviewChemistry and pharmacology of Gynostemma pentaphyllum — reviewView study →}. About 25% of the total saponin pool overlaps chemically with the ginsenosides of true ginseng — the basis of the “southern ginseng” label ^{4Reference 4Razmovski-Naumovski V et al. · 2005ReviewChemistry and pharmacology of Gynostemma pentaphyllum — reviewView study →}; bioassay-guided fractionation of the leaf has flagged sibling members such as gypenoside L and the shared ginsenoside Rd as the more antioxidant and cytotoxic saponins, but did not single out gypenoside A ^{5Reference 5Wang TX et al. · 2018In vitroBioassay-guided isolation and identification of anticancer and antioxidant compounds from Gynostemma pentaphyllum — in vitroView study →}. Related dammarane saponins are found across other Gynostemma species, but jiaogulan is the practical source.

Discovery & Synthesis

The gypenosides were first isolated and characterised from Gynostemma pentaphyllum by Japanese researchers (Takemoto and colleagues) in the early 1980s, in a systematic saponin survey that named a long series of gypenosides — gypenoside A among them — as the plant’s dammarane triterpenoid glycosides ^{3Reference 3Nguyen NH et al. · 2021ReviewTriterpenoids from the genus Gynostemma: chemistry and pharmacological activities — reviewView study →}. There is no notable total synthesis: like the ginsenosides, gypenoside A is a complex glycosylated triterpene obtained by extraction and chromatographic isolation from jiaogulan leaf, not by chemical manufacture. Commercial “gypenosides” are saponin-enriched leaf extracts (variously standardised, or not), and single-compound gypenoside A is produced only at reference-standard scale for laboratory use ^{2,3Reference 2Li X et al. · 2025ReviewGypenosides, a promising phytochemical triterpenoid: research progress on its pharmacological activity and mechanism — reviewView study →Reference 3Nguyen NH et al. · 2021ReviewTriterpenoids from the genus Gynostemma: chemistry and pharmacological activities — reviewView study →}.

Patents: not yet researched.

Toxicity & Safety

Gypenoside A carries a low toxicity flag. This reflects the broader jiaogulan safety record — the leaf has a long history of use as a tisane, and gypenosides are generally well tolerated in animal and human studies, with mild, reversible effects (mostly nausea or gastrointestinal upset) the main complaint ^{3,6Reference 3Nguyen NH et al. · 2021ReviewTriterpenoids from the genus Gynostemma: chemistry and pharmacological activities — reviewView study →Reference 6Ahn YJ et al. · 2023RCTEffects of gypenoside L-containing Gynostemma pentaphyllum extract on fatigue and physical performance: a double-blind, placebo-controlled, randomized trial — human RCTView study →}. The flag is low rather than very low only because there is no dedicated toxicology package for the isolated molecule — safety is inferred from the mixture, not measured on gypenoside A.

Safety at a Glance

✅ Low / no toxicity

• Good general tolerability. Jiaogulan tea and standardised gypenoside extracts are well tolerated in human trials, with mild GI effects the usual limit ^{3,6Reference 3Nguyen NH et al. · 2021ReviewTriterpenoids from the genus Gynostemma: chemistry and pharmacological activities — reviewView study →Reference 6Ahn YJ et al. · 2023RCTEffects of gypenoside L-containing Gynostemma pentaphyllum extract on fatigue and physical performance: a double-blind, placebo-controlled, randomized trial — human RCTView study →}.
• Metabolic and hypoglycaemic overlap. The class activates AMPK and can lower glucose ^{7Reference 7Nayyar D et al. · 2023Clinical trialGynostemma pentaphyllum increases exercise performance and alters mitochondrial respiration and AMPK in healthy males — human studyView study →}; caution alongside antidiabetic drugs is prudent for jiaogulan as a whole, though not studied for isolate A.
• Isolate-A safety is uncharacterised. No dedicated toxicity, genotoxicity or interaction dataset exists for pure gypenoside A; cautions are borrowed from the mixture.
• Preparation matters. Whole-leaf tea, standardised extract and proprietary products are not interchangeable — saponin content and profile vary widely ^{3Reference 3Nguyen NH et al. · 2021ReviewTriterpenoids from the genus Gynostemma: chemistry and pharmacological activities — reviewView study →}.

Pregnancy and lactation are decisions for the jiaogulan herb page, where intake is chosen; no reproductive-toxicity dataset exists for isolated gypenoside A.

Dosage

There is no established human dose of isolated gypenoside A — it is a research compound, not a standardised supplement, and its ~0.90% oral bioavailability means a milligram figure would not map onto delivered exposure anyway ^{2Reference 2Li X et al. · 2025ReviewGypenosides, a promising phytochemical triterpenoid: research progress on its pharmacological activity and mechanism — reviewView study →}. Human jiaogulan intake happens at the whole-plant level, where gypenoside A is one saponin among hundreds:

These are doses studied in research and are not a personal recommendation.

References

1. Huang WC, Wu SJ, Yeh KW, Liou CJ (2022). Gypenoside A from Gynostemma pentaphyllum attenuates airway inflammation and Th2 cell activities in a murine asthma model — animal model. International Journal of Molecular Sciences. https://pubmed.ncbi.nlm.nih.gov/35887041/
2. Li X, Chen Y, Wang R, Cao B, Deng T, Han J, Yang M (2025). Gypenosides, a promising phytochemical triterpenoid: research progress on its pharmacological activity and mechanism — review. Frontiers in Pharmacology. https://pubmed.ncbi.nlm.nih.gov/41181612/
3. Nguyen NH, Ha TKQ, Yang JL, Pham HTT, Oh WK (2021). Triterpenoids from the genus Gynostemma: chemistry and pharmacological activities — review. Journal of Ethnopharmacology. https://pubmed.ncbi.nlm.nih.gov/33186700/
4. Razmovski-Naumovski V, Huang THW, Tran VH, Li GQ, Duke CC, Roufogalis BD (2005). Chemistry and pharmacology of Gynostemma pentaphyllum — review. Phytochemistry Reviews. https://doi.org/10.1007/s11101-005-3754-4
5. Wang TX, Shi MM, Jiang JG (2018). Bioassay-guided isolation and identification of anticancer and antioxidant compounds from Gynostemma pentaphyllum — in vitro. RSC Advances. https://pubmed.ncbi.nlm.nih.gov/35540147/
6. Ahn YJ, Lee HS, Lee SH, et al. (2023). Effects of gypenoside L-containing Gynostemma pentaphyllum extract on fatigue and physical performance: a double-blind, placebo-controlled, randomized trial — human RCT. Phytotherapy Research. https://pubmed.ncbi.nlm.nih.gov/36877124/
7. Nayyar D, Yan X, Xu G, et al. (2023). Gynostemma pentaphyllum increases exercise performance and alters mitochondrial respiration and AMPK in healthy males — human study. Nutrients. https://pubmed.ncbi.nlm.nih.gov/38004115/
8. Lei H, Luo J, Kang L, et al. (2023). Gypenoside IX restores Akt/GSK-3β pathway and alleviates Alzheimer’s disease-like neuropathology and cognitive deficits — animal/cell model. Aging (Albany NY). https://pubmed.ncbi.nlm.nih.gov/38095632/
9. Dong SQ, Zhang QP, Zhu JX, et al. (2018). Gypenosides reverses depressive behavior via inhibiting hippocampal neuroinflammation — animal model. Biomedicine & Pharmacotherapy. https://pubmed.ncbi.nlm.nih.gov/30119182/
10. Zhang MM, Huo GM, Cheng J, et al. (2022). Gypenoside XVII, an active ingredient from Gynostemma pentaphyllum, inhibits C3aR-associated synaptic pruning in stressed mice — animal model. Nutrients. https://pubmed.ncbi.nlm.nih.gov/35745148/

View all 10 references▾